Resilience of people with diabetes mellitus during the COVID-19 pandemic

Cross-sectional study carried out with 235 people with diabetes using a form shared on social media with sociodemographic and clinical data and the Connor-Davidson resilience scale validated for the Brazilian context. Scale scores were compared with sociodemographic and clinical data using Student’s t-test, analysis of variance and Mann-Whitney.

Results:

The mean score on the resilience scale was 63.58+14.5. The highest resilience scores were evidenced in men, people with higher income, higher education, users of oral antidiabetics, who had healthy diet and who performed physical activity and follow-up with the health team.

Conclusion:

Mean resilience was lower than the score shown in the literature and groups with higher scores had better health behaviors.

Keywords:
Diabetes mellitus; COVID-19; Resilience, psychological; Disease prevention; Patient care team; Mental health; Nursing

Variables	n	%	Mean +SD	p
Total Resilience Scale			63.58+14.57
Gender (N=235)				0.033^†
Female	201	85.5	62.75+14.3
Male	34	14.5	68.50+15.0
Age (N=235)				0.279*
18(( 24	40	21.3	61.95+12.9
25(( 34	61	35.3	61.13+16.3
35(( 44	75	28.1	65.12+13.2
45(( 87	59	11.5	65.27+15.0
Marital status (N=235)				0.288^†
With partner	126	53.6	64.52+14.9
No partner	109	46.4	62.50+14.1
Religion (N = 233)				0.526^†
Yes	195	83.7	63.69+13.59
No	38	16.3	62.05+18.8
Income (Minimum Wage^‡) (N=210)				0.003*
Up to 2	49	23.3	56.86^a+17.4
3 - 4	56	26.7	62.75^ab+13.0
5 - 6	46	21.9	66.02^b+13.7
7 or +	59	28.1	66.31^b+12.6
Education level (N=235)				<0.001*
Postgraduate	98	41.7	66.41^b+14.5
Higher education	82	34.9	65.48^b+11.5
Up to high school	55	23.4	55.73^a+17.4
Work (N=235)				0.614^†
Yes	202	86	63.78+15.0
No	33	14	62.39+11.6

Variables	N	%	Mean + SD
Type of diabetes (N=233)				0.071*
Type 1	191	82	63.64+14.2
Type 2	27	11.6	67.41+13.2
LADA	15	6.4	56.60+19.6
Pharmacological Treatment (N= 232)				0.016*
Oral antidiabetics	18	7.8	68.50+13.7
Insulin	214	92.2	63.18+14.5
Comorbidities (N=235)				0.461^†
No	132	56.2	62.96+14.1
Yes	103	43.8	64.38+15.1
Complications (N=235)				0.458^†
Yes	67	28.5	62.46+16.0
No	168	71.5	64.03+13.9

Variables	n	%	Mean	p
Blood glucose monitoring (n=235)				0.770 ^‡
Yes	230	97,8	63.57+14.6
No	5	2,1	64.4+14.2
Monitoring type (n=230)				0.002*
Capillary blood glucose	125	54.4	60.44^a+15.2
Sensor	21	9.1	66.81^b+14.1
Both	84	36.5	67.4^b+12.6
Treatment support (N=232)				0.781^†
Yes	149	64.2	63.83+14.2
No	83	35.8	63.27+15.3
Healthy diet (n=235)				<0.001*
Always	43	18.3	67.86^b+15.5
Almost always	123	52.4	65.33^b+65.33
Sometimes	48	20.4	59.33^a+15.5
Almost never	21	8.9	54.33^a+17.2
Physical Exercise (n=230)				0.014*
7 times/week	12	5.2	58.50^a+19.9
5 to 6 times/week	26	11.3	68.12^b+10.6
3 to 4 times/week	54	23.5	68.15^b+13.4
1 to 2 times/week	60	26.1	63.47^a+14.1
None	78	33.9	60.71^a+14.8
Follow-up with health team (n=235)				0.011*
Telemedicine	66	28.1	67.15+13.9
In-person	121	51.5	63.48+13.5
None	48	20.4	58.94+16.6

Universidade Federal do Rio Grande do Sul. Escola de Enfermagem Rua São Manoel, 963 -Campus da Saúde , 90.620-110 - Porto Alegre - RS - Brasil, Fone: (55 51) 3308-5242 / Fax: (55 51) 3308-5436 - Porto Alegre - RS - Brazil
E-mail: revista@enf.ufrgs.br

Acompanhe os números deste periódico no seu leitor de RSS

[1] Corresponding author:
Marília Araripe Ferreira E-mail: mariliararipef@gmail.com